Calimpasan, Benang A.
HRN: 21-94-01 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
CEFUROXIME 750MG (VIAL)
10/24/2025
10/31/2025
IV
330mg
Q8h
URTI
Checking Final Appropriateness